What the $%&! Is Going On at the FDA? | Experts want to know why the agency approved a questionable Alzheimer’s drug but has withheld full approval from Covid vaccines. by Melody Schreiber |
|
|
|
Support Our Journalists Our writers and editors are fighting for a fairer world—but they need your help. Here’s a special summer offer to subscribe to The New Republic. —Ryan Kearney, executive editor |
|
| From the archives: The End of Friedmanomics The famed economist’s theories were embraced by Beltway power brokers in both parties. Finally, a Democratic president is turning the page on a legacy of ruin. by Zachary D. Carter |
|
|
--
This message was sent to [email protected] by [email protected]
To forward this message, please do not use the forward button in your email. This message was made specifically for you. Instead use the forward page in our newsletter system.
To change which lists you're subscribed to, or to unsubscribe, visit your personal preferences page.
Or you can click here to opt-out completely from all TNR Daily mailings.